These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8619904

  • 1. Suppression of plasma estradiol and progesterone concentrations by buthionine sulfoximine in female rats.
    Kang YJ, Uthus EO.
    Biochem Pharmacol; 1996 Feb 23; 51(4):567-70. PubMed ID: 8619904
    [Abstract] [Full Text] [Related]

  • 2. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
    Gopalan-Kriczky P, Hiruma S, Lotlikar PD.
    Cancer Lett; 1994 Jan 15; 76(1):25-30. PubMed ID: 8124663
    [Abstract] [Full Text] [Related]

  • 3. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD, Ragsdale SS, Benson JM, Henderson RF.
    Fundam Appl Toxicol; 1985 Oct 15; 5(5):913-9. PubMed ID: 2866140
    [Abstract] [Full Text] [Related]

  • 4. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 5. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ.
    Toxicology; 1994 Mar 11; 88(1-3):177-89. PubMed ID: 8160199
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis.
    Lopez SG, Luderer U.
    Free Radic Biol Med; 2004 Jun 01; 36(11):1366-77. PubMed ID: 15135172
    [Abstract] [Full Text] [Related]

  • 7. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Jun 01; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM, Wetterhahn KE.
    Toxicol Appl Pharmacol; 1991 Feb 01; 107(2):269-84. PubMed ID: 1994510
    [Abstract] [Full Text] [Related]

  • 10. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC, Harris JW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 01; 12(7):1171-4. PubMed ID: 3744936
    [Abstract] [Full Text] [Related]

  • 11. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
    Coursin DB, Cihla HP.
    Am Rev Respir Dis; 1988 Dec 01; 138(6):1471-9. PubMed ID: 3202501
    [Abstract] [Full Text] [Related]

  • 12. Regulation of total ovarian glutathione content in the rat.
    Jarrell JF, Sevcik M, Stuart G.
    Reprod Toxicol; 1992 Dec 01; 6(2):133-5. PubMed ID: 1350476
    [Abstract] [Full Text] [Related]

  • 13. The effect of in utero administration of buthionine sulfoximine on rat development.
    Reyes E, Ott S, Robinson B, Contreras R.
    Pharmacol Biochem Behav; 1995 Apr 01; 50(4):491-7. PubMed ID: 7617692
    [Abstract] [Full Text] [Related]

  • 14. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
    Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Viña J, Estrela JM.
    Biochem J; 1993 Jun 01; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
    [Abstract] [Full Text] [Related]

  • 15. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
    Baruchel S, Wang T, Farah R, Jamali M, Batist G.
    Biochem Pharmacol; 1995 Oct 26; 50(9):1505-8. PubMed ID: 7503802
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
    O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF.
    J Clin Oncol; 1996 Jan 26; 14(1):249-56. PubMed ID: 8558205
    [Abstract] [Full Text] [Related]

  • 17. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 18. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD, Maines MD.
    Biochem Pharmacol; 1990 May 15; 39(10):1565-71. PubMed ID: 2337413
    [Abstract] [Full Text] [Related]

  • 19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 20. Effect of depletion of glutathione by buthionine sulfoximine on lipid peroxidation in rats acutely treated with ethanol.
    Koçak-Toker N, Mutlu-Türkoğlu U, Alptekin N, Uysal M.
    Int J Biochem; 1993 Dec 15; 25(12):1765-8. PubMed ID: 8138014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.